355 related articles for article (PubMed ID: 2377209)
21. Analysis of tetanus toxin peptide/DR recognition by human T cell receptors reconstituted into a murine T cell hybridoma.
Blank U; Boitel B; Mège D; Ermonval M; Acuto O
Eur J Immunol; 1993 Dec; 23(12):3057-65. PubMed ID: 8258318
[TBL] [Abstract][Full Text] [Related]
22. Bacterial superantigen specificities of mouse T cell receptor V beta 20.
Bravo de Alba Y; Cazenave PA; Marche PN
Eur J Immunol; 1995 Dec; 25(12):3425-30. PubMed ID: 8566033
[TBL] [Abstract][Full Text] [Related]
23. Identification from a phage display library of peptides that bind to toxic shock syndrome toxin-1 and that inhibit its binding to major histocompatibility complex (MHC) class II molecules.
Sato A; Ida N; Fukuyama M; Miwa K; Kazami J; Nakamura H
Biochemistry; 1996 Aug; 35(32):10441-7. PubMed ID: 8756700
[TBL] [Abstract][Full Text] [Related]
24. Molecular requirements for T cell activation by the staphylococcal toxic shock syndrome toxin-1.
Norton SD; Schlievert PM; Novick RP; Jenkins MK
J Immunol; 1990 Mar; 144(6):2089-95. PubMed ID: 2313089
[TBL] [Abstract][Full Text] [Related]
25. Stimulation of B10.BR T cells with superantigenic staphylococcal toxins.
Callahan JE; Herman A; Kappler JW; Marrack P
J Immunol; 1990 Apr; 144(7):2473-9. PubMed ID: 2138648
[TBL] [Abstract][Full Text] [Related]
26. Superantigen and HLA-DR ligation induce phospholipase-C gamma 1 activation in class II+ T cells.
Kanner SB; Odum N; Grosmaire L; Masewicz S; Svejgaard A; Ledbetter JA
J Immunol; 1992 Dec; 149(11):3482-8. PubMed ID: 1385526
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to the HLA-DR alpha-chain.
Thibodeau J; Dohlsten M; Cloutier I; Lavoie PM; Bjork P; Michel F; Léveillé C; Mourad W; Kalland T; Sékaly RP
J Immunol; 1997 Apr; 158(8):3698-704. PubMed ID: 9103433
[TBL] [Abstract][Full Text] [Related]
28. An evolutionary conserved mechanism of T cell activation by microbial toxins. Evidence for different affinities of T cell receptor-toxin interaction.
Fleischer B; Gerardy-Schahn R; Metzroth B; Carrel S; Gerlach D; Köhler W
J Immunol; 1991 Jan; 146(1):11-7. PubMed ID: 1670601
[TBL] [Abstract][Full Text] [Related]
29. Vbeta-restricted T cell adherence to endothelial cells: a mechanism for superantigen-dependent vascular injury.
Brogan PA; Shah V; Klein N; Dillon MJ
Arthritis Rheum; 2004 Feb; 50(2):589-97. PubMed ID: 14872503
[TBL] [Abstract][Full Text] [Related]
30. Antitumor response elicited by a superantigen-transmembrane sequence fusion protein anchored onto tumor cells.
Wahlsten JL; Mills CD; Ramakrishnan S
J Immunol; 1998 Dec; 161(12):6761-7. PubMed ID: 9862706
[TBL] [Abstract][Full Text] [Related]
31. Defining a novel domain of staphylococcal toxic shock syndrome toxin-1 critical for major histocompatibility complex class II binding, superantigenic activity, and lethality.
Kum WW; Laupland KB; Chow AW
Can J Microbiol; 2000 Feb; 46(2):171-9. PubMed ID: 10721486
[TBL] [Abstract][Full Text] [Related]
32. Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor.
Dohlsten M; Hedlund G; Segren S; Lando PA; Herrmann T; Kelly AP; Kalland T
Eur J Immunol; 1991 May; 21(5):1229-33. PubMed ID: 1645269
[TBL] [Abstract][Full Text] [Related]
33. Toxic shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.
Scholl P; Diez A; Mourad W; Parsonnet J; Geha RS; Chatila T
Proc Natl Acad Sci U S A; 1989 Jun; 86(11):4210-4. PubMed ID: 2542966
[TBL] [Abstract][Full Text] [Related]
34. Characterization of T cell receptors engineered for high affinity against toxic shock syndrome toxin-1.
Buonpane RA; Moza B; Sundberg EJ; Kranz DM
J Mol Biol; 2005 Oct; 353(2):308-21. PubMed ID: 16171815
[TBL] [Abstract][Full Text] [Related]
35. [Superantigens and antigen recognition of T lymphocytes].
Gülmezoğlu E
Mikrobiyol Bul; 1993 Apr; 27(2):164-70. PubMed ID: 8502189
[TBL] [Abstract][Full Text] [Related]
36. Interactions between staphylococcal superantigens and MHC class II molecules.
Labrecque N; Thibodeau J; Sékaly RP
Semin Immunol; 1993 Feb; 5(1):23-32. PubMed ID: 8467091
[TBL] [Abstract][Full Text] [Related]
37. V alpha domain modulates the multiple topologies of mouse T cell receptor V beta20/staphylococcal enterotoxins A and E complexes.
Bravo de Alba Y; Marche PN; Cazenave PA; Cloutier I; Sekaly RP; Thibodeau J
Eur J Immunol; 1997 Jan; 27(1):92-9. PubMed ID: 9022003
[TBL] [Abstract][Full Text] [Related]
38. Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptors.
Al-Daccak R; Mehindate K; Damdoumi F; Etongué-Mayer P; Nilsson H; Antonsson P; Sundström M; Dohlsten M; Sékaly RP; Mourad W
J Immunol; 1998 Jan; 160(1):225-32. PubMed ID: 9551975
[TBL] [Abstract][Full Text] [Related]
39. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
40. Identification of HLA-DR alpha chain residues critical for binding of the toxic shock syndrome toxin superantigen.
Panina-Bordignon P; Fu XT; Lanzavecchia A; Karr RW
J Exp Med; 1992 Dec; 176(6):1779-84. PubMed ID: 1460432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
